MedTrace Logo

Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration

NCT05703867 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 404

Last updated 2023-01-31

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of transpalpebral microcurrent stimulation as a therapy for dry age-related macular degeneration.

Participants are assessed at baseline for visual acuity and treated for 4 consecutive days for a total of 8 sessions (2 per day) with microcurrent stimulation. A follow-up visit is conducted to evaluate the participant and collect follow-up visual acuity.

Conditions

  • Age-Related Macular Degeneration
  • Nonexudative Age-related Macular Degeneration

Interventions

DEVICE

Active microcurrent therapy

Non-invasive transpalpebral microcurrent therapy delivery to the upper and lower eyelids

Sponsors & Collaborators

  • Professor Timothy Jackson, King's College

    collaborator UNKNOWN

  • i-Lumen Scientific, Inc.

    collaborator INDUSTRY

  • Jarding, John, OD

    lead INDIV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-01-31
Primary Completion
1999-12-31
Completion
1999-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05703867 on ClinicalTrials.gov